glp 1 agonist india Glenmark launches biosimilar of anti-diabetic drug, Liraglutide, in Weight Loss Drugs In India:

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

Manifestations can vary from isolated liver enzyme elevation to fulminant hepatic failure

Insulin and incretins are compounds with multiple effects on neurodegenerative processes

these signals are hypothesis-generating and should not be interpreted as confirmed causal risks